Study guide
7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics
NPLEX Part I — Biomedical Sciences Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Pacing, and GEA Strategy
1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards
2 Chapter 2: Gross Anatomy & Musculoskeletal System
2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures
3 Chapter 3: Histology & Microscopic Anatomy
3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium
4 Chapter 4: Neuroanatomy & Special Senses
4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation
5 Chapter 5: Embryology & Developmental Anatomy
5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology
6 Chapter 6: Cellular & General Physiology
6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle
7 Chapter 7: Cardiovascular & Respiratory Physiology
7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing
8 Chapter 8: Renal, Fluid, & Acid-Base Physiology
8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms
9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology
9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation
10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism
10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport
11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics
11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics
12 Chapter 12: Immunology & Immunopathology
12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
13 Chapter 13: Medical Microbiology
13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens
14 Chapter 14: General Pathology & Neoplasia
14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors
15 Chapter 15: Systems Pathology & Disease Mechanisms
15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract
7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics
Key Takeaways Explain This Topic AI
Residual Volume (RV) and capacities containing RV (FRC and TLC) cannot be measured by simple spirometry and require helium dilution or body plethysmography.
Obstructive lung diseases are characterized by impaired airflow during exhalation with an FEV1/FVC ratio < 0.70, whereas restrictive lung diseases preserve or increase the FEV1/FVC ratio while markedly reducing TLC.
Intrapleural pressure (Pip) is negative at rest (-4 cm H2O) due to opposing elastic recoils of the lung and chest wall, becoming more negative (-8 cm H2O) during active inspiration.
Transpulmonary pressure (Ptp = Palv - Pip) represents the distending pressure required to keep alveoli expanded against their intrinsic elastic recoil.
Pulmonary surfactant (dipalmitoylphosphatidylcholine) synthesized by Type II pneumocytes reduces surface tension in smaller alveoli, preventing alveolar collapse according to the Law of Laplace (P = 2T/r).
Last updated: July 2026
7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics
The primary function of the respiratory system is gas exchange between atmospheric air and pulmonary capillary blood. This process depends on pulmonary mechanics: the structural properties, pressure gradients, and volume changes that drive ventilation of the alveolar space.
Standard Lung Volumes and Capacities
Lung volumes are discrete, non-overlapping quantities of gas measured at specific phases of respiration. Lung capacities consist of combinations of two or more lung volumes.
Primary Lung Volumes
Tidal Volume (TV or V T V_T V T ): Volume of air inspired or expired during normal, quiet breathing (~500 mL).
Inspiratory Reserve Volume (IRV): Maximum volume of air that can be forcibly inspired above a normal tidal inspiration (~3000 mL).
Expiratory Reserve Volume (ERV): Maximum volume of air that can be forcibly expired following a normal tidal expiration (~1100 mL).
Residual Volume (RV): Volume of air remaining in the lungs after maximal forced expiration (~1200 mL). RV cannot be measured by standard spirometry because it cannot be exhaled; it requires gas dilution techniques (e.g., helium dilution) or body plethysmography.
Derived Lung Capacities
Vital Capacity (VC): Total volume of air that can be expired after maximal inspiration: V C = T V + I R V + E R V ( ∼ 4700 mL ) VC = TV + IRV + ERV \quad (\sim 4700\text{ mL}) V C = T V + I R V + ER V ( ∼ 4700 mL )
Total Lung Capacity (TLC): Total volume of gas contained in the lungs following maximal inspiration: T L C = V C + R V = T V + I R V + E R V + R V ( ∼ 5900 mL ) TLC = VC + RV = TV + IRV + ERV + RV \quad (\sim 5900\text{ mL}) T L C = V C + R V = T V + I R V + ER V + R V ( ∼ 5900 mL )
Functional Residual Capacity (FRC): Volume of air remaining in the lungs at the end of a normal tidal expiration: F R C = E R V + R V ( ∼ 2300 mL ) FRC = ERV + RV \quad (\sim 2300\text{ mL}) FRC = ER V + R V ( ∼ 2300 mL ) FRC represents the mechanical equilibrium point of the respiratory system, where inward elastic recoil of the lungs equals outward chest wall expansion forces.
Inspiratory Capacity (IC): I C = T V + I R V IC = TV + IRV I C = T V + I R V (~3500 mL).
Dead Space Mechanics
Anatomical Dead Space ( V D V_D V D ): Volume of conducting airways (nose to terminal bronchioles) where no gas exchange occurs (~150 mL, or ~1 mL per lb of body weight).
Physiological Dead Space: Total volume of air that does not participate in gas exchange, combining anatomical dead space with non-perfused alveolar dead space. Quantified using the Bohr Equation : V D = V T × ( P a C O 2 − P E C O 2 P a C O 2 ) V_D = V_T \times \left( \frac{PaCO_2 - PECO_2}{PaCO_2} \right) V D = V T × ( P a C O 2 P a C O 2 − PEC O 2 )
Where P a C O 2 PaCO_2 P a C O 2 is arterial CO 2 \text{CO}_2 CO 2 partial pressure and P E C O 2 PECO_2 PEC O 2 is mixed expired CO 2 \text{CO}_2 CO 2 partial pressure.
Spirometry: Obstructive vs. Restrictive Lung Disease
Dynamic spirometry measures forced expiratory flow rates, primarily Forced Expiratory Volume in 1 second ( FEV 1 \text{FEV}_1 FEV 1 ) and Forced Vital Capacity (FVC) . Spirometry Evaluation:
- Check FEV1 / FVC Ratio
- ├── < 0.70 (70%) ──> OBSTRUCTIVE PATTERN (Asthma, COPD, Emphysema)
- └── ≥ 0.70 (70%) ──> Check TLC
- ├── Low TLC ──> RESTRICTIVE PATTERN (Fibrosis, ARDS)
- └── Normal TLC ──> NORMAL SPIROMETRY
- Comparative Spirometric Profiles
Parameter Normal Obstructive Pattern (e.g., COPD, Asthma) Restrictive Pattern (e.g., Pulmonary Fibrosis)
FEV 1 \text{FEV}_1 FEV 1 ~80% predicted Markedly Decreased ( < 80 % <80\% < 80% ) Decreased ( < 80 % <80\% < 80% )
FVC ~80% predicted Normal or Moderately Decreased Markedly Decreased ( < 80 % <80\% < 80% )
FEV 1 / FVC \text{FEV}_1 / \text{FVC} FEV 1 / FVC Ratio ~0.80 (80%) Decreased ( < 0.70 or 70 % <0.70\text{ or }70\% < 0.70 or 70% ) Normal or Increased ( ≥ 0.70 to 0.90 \,\ge 0.70\text{ to }0.90 ≥ 0.70 to 0.90 )
TLC & RV Normal Increased (Air trapping, hyperinflation) Decreased (Low lung compliance)
Obstructive Diseases: Airway resistance during exhalation is elevated due to bronchial lumen narrowing (asthma, chronic bronchitis) or loss of elastic recoil (emphysema). Exhalation is prolonged, trapping gas in lungs and raising RV and TLC.
Restrictive Diseases: Expansion of lung parenchyma is restricted by interstitial inflammation/fibrosis or neuromuscular weakness. Lung compliance drops; both FEV 1 \text{FEV}_1 FEV 1 and FVC decline proportionally, maintaining a normal or elevated ratio.
Mechanics of Breathing & Pressure Relationships
Ventilation is driven by pressure differentials established between atmospheric pressure ( P a t m = 0 cm H 2 O P_{atm} = 0\text{ cm H}_2\text{O} P a t m = 0 cm H 2 O baseline), alveolar pressure ( P a l v P_{alv} P a l v ), and intrapleural pressure ( P i p P_{ip} P i p ).
Key Respiratory Pressures
Intrapleural Pressure ( P i p P_{ip} P i p ): Pressure within the fluid-filled intrapleural space. Under resting baseline conditions at FRC, P i p P_{ip} P i p is always negative ( − 4 cm H 2 O -4\text{ cm H}_2\text{O} − 4 cm H 2 O ) because the lungs tend to collapse inward due to elastic recoil, while the chest wall tends to spring outward. During active inspiration, diaphragm contraction enlarges the thoracic cavity, causing P i p P_{ip} P i p to become more negative ( − 8 cm H 2 O -8\text{ cm H}_2\text{O} − 8 cm H 2 O ) .
Alveolar Pressure ( P a l v P_{alv} P a l v ): Pressure within alveoli. At rest (end-expiration), P a l v = 0 cm H 2 O P_{alv} = 0\text{ cm H}_2\text{O} P a l v = 0 cm H 2 O . During inspiration, expanding lung volume drops P a l v P_{alv} P a l v to − 1 cm H 2 O -1\text{ cm H}_2\text{O} − 1 cm H 2 O , drawing ambient air inward. During expiration, elastic lung recoil raises P a l v P_{alv} P a l v to + 1 cm H 2 O +1\text{ cm H}_2\text{O} + 1 cm H 2 O , expelling air.
Transpulmonary Pressure ( P t p P_{tp} P tp ): Distending pressure across the alveolar wall: P t p = P a l v − P i p P_{tp} = P_{alv} - P_{ip} P tp = P a l v − P i p P t p P_{tp} P tp is always positive under normal conditions; a higher P t p P_{tp} P tp maintains greater alveolar expansion.
- Lung Compliance, Elastic Recoil, & Surface Tension
- Compliance Mechanics
Lung compliance represents the ease with which the lungs expand per unit change in transpulmonary pressure: Compliance ( C ) = Δ V Δ P t p \text{Compliance } (C) = \frac{\Delta V}{\Delta P_{tp}} Compliance ( C ) = Δ P tp Δ V
Increased Compliance: Observed in emphysema due to destruction of elastic alveolar septa by neutrophil elastase. Lungs expand easily but lose elastic recoil, resulting in dynamic airway collapse during forced expiration.
Decreased Compliance: Observed in pulmonary fibrosis , pulmonary edema, and Infant Respiratory Distress Syndrome (IRDS). Lungs become stiff, requiring substantial pressure changes to achieve minimal tidal expansion.
Surface Tension & Law of Laplace
Alveoli are lined by a thin fluid film. Liquid molecules attract one another, creating surface tension ( T T T ) that exerts an inward collapsing pressure ( P P P ) on the alveolus, as defined by the Law of Laplace for a spherical structure: P = 2 T r P = \frac{2T}{r} P = r 2 T
Where P P P is collapsing pressure, T T T is surface tension, and r r r is alveolar radius.
Biophysical Implication: Without intervention, smaller alveoli (smaller radius r r r ) would experience significantly higher collapsing pressures ( P P P ) than larger alveoli, causing smaller alveoli to collapse and discharge their air into larger ones (atelectasis).
Physiological Function of Pulmonary Surfactant
Synthesis: Synthesized and secreted by Type II pneumocytes (stored in intracellular lamellar bodies).
Composition: Complex mixture of phospholipids, primarily dipalmitoylphosphatidylcholine (DPPC) , alongside surfactant proteins (SP-A, SP-B, SP-C, SP-D).
Mechanism: Intersperses between water molecules at the air-water interface, reducing surface tension ( T T T ). As an alveolus shrinks during exhalation, surfactant molecules become more tightly packed, reducing surface tension proportionately more in smaller alveoli. This equalizes collapsing pressure across alveoli of varying sizes, preventing alveolar collapse, reducing work of breathing, and increasing overall lung compliance.